Early hormonal changes during valproate or carbamazepine treatment

@article{Rtty2001EarlyHC,
  title={Early hormonal changes during valproate or carbamazepine treatment},
  author={Johanna R{\"a}tty{\"a} and Arto J. Pakarinen and Mikael Knip and M Repo-Outakoski and Vilho V. Myllyl{\"a} and Jouko Isoj{\"a}rvi},
  journal={Neurology},
  year={2001},
  volume={57},
  pages={440 - 444}
}
Background: Long-term treatment with valproate (VPA) or carbamazepine (CBZ) may induce reproductive endocrine disorders in patients with epilepsy. Methods: Serum concentrations of reproductive hormones were studied in 17 women and 22 men with recently diagnosed epilepsy before they started either VPA or CBZ medication, and 1 and 3 months later. Results: No weight gain or clinical signs of hormonal disorders were observed during the follow-up. The mean serum levels of testosterone, luteinizing… 

Tables from this paper

Effects of sodium valproate monotherapy on reproductive hormonal levels in adult male epileptic patients
TLDR
VPA monotherapy might be associated with significant increase in serum testosterone level with insignificant effects on serum prolactin, FSH, LH and E2 in adult male epileptic patients and the duration of therapy and daily dose have no influence on such effect.
Interactions between antiepileptic drugs and hormones
Antiepileptic drugs, sex hormones, and PCOS
TLDR
The use of the liver enzyme–inducing AEDs—such as phenobarbital, phenytoin, and carbamazepine—can increase serum sex hormone–binding globulin concentrations, leading to diminished bioactivity of testosterone (T) and estradiol.
Long-Term Effects of Valproic Acid on Reproductive Endocrine Functions in Turkish Women with Epilepsy
TLDR
No statistically significant dose or duration-related rise of risk for patients who developed PCOS and menstrual irregularities and those who were not on long-term VPA therapy support the hypothesis of early occurring VPA-associated metabolic and endocrine changes.
Effect of epilepsy and antiepileptic drugs on male reproductive health
TLDR
CBZ, OXC, and VPA are associated with sperm abnormalities in men with epilepsy, in addition, VPA-treated men with generalized epilepsy who have abnormal sperm may have reduced testicular volume.
Metabolic and Menstrual Disturbances in Women with Epilepsy
TLDR
Women with epilepsy on VPA tend to be more obese, and more frequently have metabolic and/or menstrual abnormalities than epileptic women on CBZ or LTG.
Reproductive dysfunction in women with epilepsy
TLDR
Treatment with these agents should be considered in women who develop reproductive endocrine dysfunction during treatment with the older AEDs, including phenytoin and carbamazepine, which may result in menstrual disorders in some women receiving long-term CBZ treatment.
...
...

References

SHOWING 1-10 OF 21 REFERENCES
Menstrual Disorders in Women with Epilepsy Receiving Carbamazepine
TLDR
Long‐term CBZ treatment results in increased serum SHBG levels and decreased estradiol effect, which correlate with the frequency of menstrual disorders in CBZ‐treated women with epilepsy.
Carbamazepine, Phenytoin, Sex Hormones, and Sexual Function in Men with Epilepsy
TLDR
Serum sex hormone binding globulin levels increased and free androgen index (FAI) decreased during CBZ treatment, and these changes correlated with duration of CBZ therapy, which may be the primary cause of hyposexuality common in men with epilepsy.
Valproate‐induced hyperandrogenism during pubertal maturation in girls with epilepsy
TLDR
Valproate may induce hyperandrogenism in girls with epilepsy during the sensitive period of pubertal maturation, and the frequency of hyper androgenism increases with Pubertal development, which emphasizes the importance of careful endocrine observation of girls taking valproate for epilepsy.
Obesity and endocrine disorders in women taking valproate for epilepsy
TLDR
The weight gain can be progressive, and is associated with hyperinsulinemia and low serum levels of insulin‐like growth factor‐binding protein 1, which may lead to hyperandrogenism and polycystic ovaries.
Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
TLDR
Menstrual disturbances, polycystic ovaries, and hyperandrogenism are often encountered in women taking valproate for epilepsy.
Valproate, lamotrigine, and insulin‐mediated risks in women with epilepsy
TLDR
Valproate induces a metabolic syndrome with centripetal obesity, hyperinsulinemia lipid abnormalities, and polycystic ovaries/hyperandrogenism in women with epilepsy that can be reduced by substituting lamotrigine for valproate.
Effects of valproate-induced alteration of the GABAergic system on pulsatile luteinizing hormone secretion in ovariectomized women.
TLDR
It is concluded that sustained serum valproate levels do not alter pulsatile secretion of LH in ovariectomized women, implying that, in humans, GABA is probably not a decisive factor in the regulation of the GnRH pulse generator.
Liver Enzyme Induction and Serum Lipid Levels After Replacement of Carbamazepine with Oxcarbazepine
TLDR
OCBZ may be the preferable antiepileptic drug (AED) with regard to the effects of the medication on lipid metabolism and serum lipid levels in 12 male patients with epilepsy after replacing carbamazepine medication with oxcarbazepine.
A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.
TLDR
The data demonstrate a dose-dependent degree of enzyme induction in patients receiving therapeutic doses of these anticonvulsants, and significant positive correlations were found between the dosage of CBZ, DPH, PMD and PB and both indices of enzymes induction.
Clinical implications of hyperinsulinaemia in women
TLDR
It is postulate that both direct ovarian and indirect actions of insulin play important roles in determining androgen concentrations in women and the cause of moderate hyperinsulinaemia, the action of insulin on the normal ovary, and the importance of adverse surrogate risk factors for heart disease in hyper insulinaemic women are understood.
...
...